10-Q Filing

ST JUDE MEDICAL INC CIK: 203077 Q3 2010

Filing Information

Form Type	10-Q
Accession Number	`0000897101-10-002229`
Period End Date	20100930
Filing Date	20101110
Fiscal Year	2010
Fiscal Period	Q3
XBRL Instance	stj-20101002.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 70 Cash Flow Statement 65

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$34.95M	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$36.14M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$392.93M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$798.28M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$136.44M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$851.61M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $36,138 at October 2, 2010 and $34,947 at January 2, 2010	`AccountsReceivableNetCurrent`	$1.26B	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $36,138 at October 2, 2010 and $34,947 at January 2, 2010	`AccountsReceivableNetCurrent`	$1.17B	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Inventories	`InventoryNet`	$659.96M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Inventories	`InventoryNet`	$688.66M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetCurrent`	$164.74M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetCurrent`	$164.53M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Other	`OtherAssetsCurrent`	$172.00M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	328.77M	shares	Point-in-time
Other	`OtherAssetsCurrent`	$251.29M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	324.54M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$3.22B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.56B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	324.54M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	328.77M	shares	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$1.95B	USD	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$2.15B	USD	Point-in-time
Less: accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$895.32M	USD	Point-in-time
Less: accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$796.33M	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.15B	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.26B	USD	Point-in-time
Goodwill	`Goodwill`	$2.08B	USD	Point-in-time
Goodwill	`Goodwill`	$2.01B	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$469.55M	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$456.14M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$365.38M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$250.53M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$7.39B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$6.43B	USD	Point-in-time
Current debt obligations	`DebtCurrent`	$334.79M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$132.54M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$183.50M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$13.50M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$269.29M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$269.80M	USD	Point-in-time
Other	`OtherLiabilitiesCurrent`	$276.92M	USD	Point-in-time
Other	`OtherLiabilitiesCurrent`	$317.19M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.07B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$730.22M	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.59B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.99B	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$132.39M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$120.83M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$314.94M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$355.34M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.10B	USD	Point-in-time
Total liabilities	`Liabilities`	$3.19B	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 328,768,791 and 324,537,581 shares issued and outstanding at October 2, 2010 and January 2, 2010, respectively)	`CommonStockValue`	$32.88M	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 328,768,791 and 324,537,581 shares issued and outstanding at October 2, 2010 and January 2, 2010, respectively)	`CommonStockValue`	$32.45M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$180.12M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$5.86M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$3.19B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$3.89B	USD	Point-in-time
Cumulative translation adjustment	`AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax`	$82.03M	USD	Point-in-time
Cumulative translation adjustment	`AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax`	$72.28M	USD	Point-in-time
Unrealized gain on available-for-sale securities	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$12.00M	USD	Point-in-time
Unrealized gain on available-for-sale securities	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$13.16M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$4.19B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$3.32B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$7.39B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$6.43B	USD	Point-in-time

Income Statement 70 line items

Line Item	Tag	Value	Unit	Period
Net sales	`SalesRevenueNet`	$3.81B	USD	3 Qtrs
Net sales	`SalesRevenueNet`	$1.24B	USD	1 Quarter
Net sales	`SalesRevenueNet`	$3.48B	USD	3 Qtrs
Net sales	`SalesRevenueNet`	$1.16B	USD	1 Quarter
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$339.82M	USD	1 Quarter
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$899.71M	USD	3 Qtrs
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$1.01B	USD	3 Qtrs
Cost of sales before special charges	`CostOfSalesBeforeSpecialCharges`	$299.67M	USD	1 Quarter
Special charges	`SpecialCharges`	$6.06M	USD	1 Quarter
Special charges	`SpecialCharges`	$6.06M	USD	3 Qtrs
Special charges	`SpecialCharges`	-	USD	3 Qtrs
Special charges	`SpecialCharges`	-	USD	1 Quarter
Total cost of sales	`CostOfGoodsSold`	$339.82M	USD	1 Quarter
Total cost of sales	`CostOfGoodsSold`	$1.01B	USD	3 Qtrs
Total cost of sales	`CostOfGoodsSold`	$305.73M	USD	1 Quarter
Total cost of sales	`CostOfGoodsSold`	$905.77M	USD	3 Qtrs
Gross profit	`GrossProfit`	$2.81B	USD	3 Qtrs
Gross profit	`GrossProfit`	$900.09M	USD	1 Quarter
Gross profit	`GrossProfit`	$853.88M	USD	1 Quarter
Gross profit	`GrossProfit`	$2.57B	USD	3 Qtrs
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$427.23M	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$1.28B	USD	3 Qtrs
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$1.33B	USD	3 Qtrs
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$438.72M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$424.63M	USD	3 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$456.47M	USD	3 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$150.13M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$142.22M	USD	1 Quarter
Purchased in-process research and development charges	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	-	USD	3 Qtrs
Purchased in-process research and development charges	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$12.24M	USD	1 Quarter
Purchased in-process research and development charges	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$12.24M	USD	3 Qtrs
Purchased in-process research and development charges	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	-	USD	1 Quarter
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$42.39M	USD	3 Qtrs
Special charges	`RestructuringSettlementAndImpairmentProvisions`	$42.39M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$298.98M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$1.01B	USD	3 Qtrs
Operating profit	`OperatingIncomeLoss`	$828.95M	USD	3 Qtrs
Operating profit	`OperatingIncomeLoss`	$242.03M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-23.59M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-35.87M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-11.11M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-51.66M	USD	3 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$287.87M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$218.44M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$958.09M	USD	3 Qtrs
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$793.08M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$257.10M	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$79.49M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$51.50M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$205.51M	USD	3 Qtrs
Net earnings	`NetIncomeLoss`	$587.58M	USD	3 Qtrs
Net earnings	`NetIncomeLoss`	$700.99M	USD	3 Qtrs
Net earnings	`NetIncomeLoss`	$208.38M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$166.94M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$2.14	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$1.71	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$0.49	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.63	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$2.13	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.48	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.63	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$1.69	USD	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	340.65M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	326.82M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	344.42M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	328.23M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	348.24M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	329.10M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	344.30M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	329.93M	shares	1 Quarter

Cash Flow Statement 65 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`NetIncomeLoss`	$166.94M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$208.38M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$700.99M	USD	3 Qtrs
Net earnings	`NetIncomeLoss`	$587.58M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$175.81M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$156.64M	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$158.00K	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$692.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$44.13M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$53.14M	USD	3 Qtrs
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$19.13M	USD	3 Qtrs
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$10.96M	USD	3 Qtrs
Investment impairment charges	`ImpairmentOfInvestments`	$8.30M	USD	3 Qtrs
Investment impairment charges	`ImpairmentOfInvestments`	$8.30M	USD	1 Quarter
Gain on sale of investments	`AvailableForSaleSecuritiesGrossRealizedGainLossNet`	$4.93M	USD	1 Quarter
Gain on sale of investments	`AvailableForSaleSecuritiesGrossRealizedGainLossNet`	$4.93M	USD	3 Qtrs
Purchased in-process research and development charges	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	-	USD	1 Quarter
Purchased in-process research and development charges	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$12.24M	USD	3 Qtrs
Purchased in-process research and development charges	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	-	USD	3 Qtrs
Purchased in-process research and development charges	`ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff`	$12.24M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-7.44M	USD	3 Qtrs
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$1.11M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$53.95M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$89.31M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$118.27M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$10.65M	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$51.68M	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$22.68M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$22.68M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-35.40M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$4.88M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$977.00K	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$553.38M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$791.56M	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$236.33M	USD	3 Qtrs
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$226.30M	USD	3 Qtrs
Business acquisition payments, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$128.90M	USD	3 Qtrs
Business acquisition payments, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$14.79M	USD	3 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$15.35M	USD	3 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$113.57M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-468.77M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-266.47M	USD	3 Qtrs
Proceeds from exercise of stock options and stock issued	`ProceedsFromStockOptionsExercised`	$87.39M	USD	3 Qtrs
Proceeds from exercise of stock options and stock issued	`ProceedsFromStockOptionsExercised`	$107.34M	USD	3 Qtrs
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$19.13M	USD	3 Qtrs
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$10.96M	USD	3 Qtrs
Common stock repurchased, including related costs	`PaymentsForRepurchaseOfCommonStock`	$500.00M	USD	3 Qtrs
Borrowings under debt facilities	`ProceedsFromIssuanceOfLongTermDebt`	$671.09M	USD	3 Qtrs
Borrowings under debt facilities	`ProceedsFromIssuanceOfLongTermDebt`	$1.41B	USD	3 Qtrs
Payments under debt facilities	`RepaymentsOfLongTermDebt`	$655.72M	USD	3 Qtrs
Payments under debt facilities	`RepaymentsOfLongTermDebt`	$645.77M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$133.68M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$366.50M	USD	3 Qtrs
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$2.22M	USD	3 Qtrs
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$8.43M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$661.84M	USD	3 Qtrs
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$458.69M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$851.61M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$136.44M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$392.93M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$798.28M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$851.61M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$136.44M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$392.93M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$798.28M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.